Date: 12 December
Time: 15:30 GMT
Length: 60 minutes
Rapid microbiological methods have recently transitioned from being a “nice to have” to have a “must have” solution to help accelerate and control biopharmaceutical production and preserve patient safety. Unfortunately, they have historically been implemented with limited scope, focusing on specific sample types and applications most suitable for or limited by the technology being used. Many quality control laboratories and their manufacturing operations partner groups are then incapable of applying these rapid methods at multiple points along the biomanufacturing process and for in-process controls. Opportunities exist to utilize certain rapid microbiological methods to their maximum potential by adding quality check points to obtain results in a shorter time, reducing the overall impact of contaminations.
This webinar describes these control points, the impact of contamination, and how an amplified adenosine trisphosphate (ATP) bioluminescence detection method can be applied from cell culture to final product sterility, generating in-process control results in less than 48 hours and final products to be released in as little as 6 days.